Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.2 EUR | +1.08% | -12.74% | -12.74% |
Sales 2024 * | 88.37B 81.84B | Sales 2025 * | 90.78B 84.07B | Capitalization | 364B 337B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 20.41B | Net income 2025 * | 23.09B 21.38B | EV / Sales 2024 * | 4.04 x |
Net cash position 2024 * | 7B 6.48B | Net cash position 2025 * | 21.07B 19.52B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
15.9
x | Employees | 131,900 |
Yield 2024 * |
3.19% | Yield 2025 * |
3.33% | Free-Float | 77.07% |
Latest transcript on Johnson & Johnson
1 day | +1.07% | ||
1 week | -12.74% | ||
Current month | -12.74% | ||
1 month | -12.74% | ||
3 months | -12.74% | ||
6 months | -12.74% | ||
Current year | -12.74% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 138.7 | -12.74% | 50 |
End-of-day quote Bulgaria S.E., May 09, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+32.39% | 586B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock